Alzheimer's Disease Management

Pharmacological Treatment

The American Academy of Family Physicians recommends cholinesterase inhibitors as first-line treatment for mild to moderate Alzheimer's disease, with donepezil, rivastigmine, and galantamine being suitable options 1, 2, 3
For moderate to severe Alzheimer's disease, memantine alone or in combination with donepezil is recommended, with the American Academy of Family Physicians suggesting its use based on disease severity and symptom profile 2, 3
Cholinesterase inhibitors may improve cognitive symptoms and reduce behavioral disturbances, with common side effects including gastrointestinal symptoms that can be mitigated by taking medication with food 3, 4

The American Academy of Family Physicians suggests providing a predictable daily routine, using the "three R's" approach, creating a safe environment, and using orientation aids to manage behavioral symptoms 5, 6
Cognitive training activities, such as reading and playing games, can be beneficial, as can music therapy, art therapy, and reminiscence therapy, according to the American Academy of Family Physicians 2, 5
Physical exercise, including aerobic and anaerobic activities, can be beneficial for patients with Alzheimer's disease, with the American Academy of Family Physicians recommending its use 2, 5
A brain-healthy diet, including nuts, berries, green leafy vegetables, fish, and a Mediterranean diet, is recommended by the American Academy of Family Physicians 2, 6

The American Academy of Family Physicians recommends a step-wise approach, starting with non-pharmacological interventions, such as identifying and addressing triggers, modifying the environment, and ensuring comorbid conditions are optimally treated 5, 6
If non-pharmacological approaches are insufficient, pharmacological treatment, such as cholinesterase inhibitors or selective serotonin reuptake inhibitors, can be added, with the American Academy of Family Physicians suggesting their use based on symptom profile 4, 6

The American Academy of Family Physicians recommends registering patients at risk for wandering in the Alzheimer's Association Safe Return Program and considering end-of-life care planning early in the disease course 4, 5, 6
The American Academy of Family Physicians suggests avoiding medications with anticholinergic side effects, which can worsen cognitive symptoms, and relying solely on pharmacological approaches without implementing non-pharmacological strategies 4, 7, 8